Showing results (2851-2860 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|January 20, 2025
Machine learning models for predicting postoperative peritoneal metastasis after hepatocellular carcinoma rupture: a multicenter cohort study in ChinaFeng Xia, Qian Chen, Zhicheng Liu, et al.
The Oncologist|January 23, 2025
Ovarian clear cell carcinoma: open questions on the management and treatment algorithmRoberta Rosso, Margherita Turinetto, Fulvio Borella, et al.
The Oncologist|January 23, 2025
Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancerFerdinandos Skoulidis, Bob T Li, Maximilian Hochmair, et al.
The Oncologist|January 20, 2025
A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancerEmiliano Calvo, Bernard Doger, Joan Carles, et al.
The Oncologist|November 26, 2024
Associations of social vulnerability index with patient-reported outcomes in women treated with chemotherapy for early-stage breast cancerNatalie Almond, Allison M Deal, Annie Page, et al.
The Oncologist|November 28, 2024
Patients' psychosocial attributes and aggressiveness of cancer treatments near the end of lifeLéa Restivo, Philippe Rochigneux, Anne-Déborah Bouhnik, et al.
The Oncologist|November 26, 2024
Changes in clinical presentation, management, and survival outcomes in patients affected by colorectal cancer following COVID-19 pandemicAlessandro Parisi, Riccardo Giampieri, Silvia Villani, et al.
The Oncologist|November 26, 2024
The methylation signature of hepatocellular carcinoma trajectory based on pseudotime and chronological time for predicting precancerous patientsKang Li, Chaoran Zang, Yanan Zhao, et al.
The Oncologist|December 20, 2024
Weight loss in patients on osimertinib for metastatic EGFR-mutant non-small cell lung cancerLanyi Nora Chen, Xin Ma, Benjamin Herzberg, et al.
The Oncologist|December 20, 2024
Incidence of patient-reported fatigue developing on palbociclib and endocrine therapy for advanced HR+ HER2- breast cancerShadab A Rahman, Hanneke Poort, Deborah Schrag, et al.
Pageof 571